Orally disintegrating tablet: Schizophrenia: Adults: Initially 10-15 mg/day.
Recommended dose: 10-15 mg/day; Maximum: 30 mg/day.
Adolescents: Initially 2 mg/day.
Recommended dose: 10 mg/day; Maximum: 30 mg/day.
Bipolar mania: Adults: Monotherapy: Initially 15 mg.
Recommended dose: 15 mg/day; Maximum: 30 mg/day.
Adjunct therapy to lithium or valproate: Adults: 10-15 mg/day.
Recommended dose: 15 mg/day; Maximum: 30 mg/day.
Monotherapy or adjunct therapy to lithium or valproate: Children: Initially 2 mg/day.
Recommended dose: 10 mg/day; Maximum: 30 mg/day.
Major depressive disorders: Adults: Adjunct therapy to antidepressants: Initially 2-5 mg/day.
Recommended dose: 5-10 mg/day; Maximum: 15 mg/day.
Irritability related to autism disorders: Children: Initially 2 mg/day.
Recommended dose: 5-10 mg/day; Maximum: 15 mg/day.
Tourette's disorders: Patients <50 kg: Initially 2 mg/day.
Recommended dose: 5 mg/day; Maximum: 10 mg/day.
Patients ≥50 kg: Initially 2 mg/day.
Recommended dose: 10 mg/day; Maximum: 20 mg/day.
Oral solution: Idiopathic & post-encephalitic parkinsonism: Initially 1 mg/day on day 1, then increase to 2 mg 2-3 times daily for 3-5 days.
Post-encephalitis: 12-15 mg daily.
Drug-induced parkinsonism (extrapyramidal effects): Adults: Initially 1 mg, may be increased until the symptoms subsides. Total daily dose: 5-15 mg.
Other Services
Country
Account